Roots and stems: Stem cells in cancer

Nature Medicine

Volumn 12, Issue 3, 2006, Pages 296-300

  Polyak, Kornelia ^a,b   Hahn, William C ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; TRASTUZUMAB;

BREAST CANCER; CANCER GROWTH; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENESIS; CELL POPULATION; CHRONIC MYELOID LEUKEMIA; CYTOLOGY; DISEASE COURSE; GENE IDENTIFICATION; HUMAN; MUTATION; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; TUMOR STEM CELLS;

EID: 33644826473     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1379     Document Type: Review

References (63)

1. Al-Hajj, M. & Clarke, M.F. Self-renewal and solid tumor stem cells. Oncogene 23, 7274-7282 (2004).
2. Cohnheim, V. Congenitales, quergestreiftes muskelsarkom der nieren. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 65, 64-69 (1875).
3. Makino, S. Further evidence favoring the concept of the stem cell in ascites tumors of rats. Ann. NY Acad. Sci. 63, 818-830 (1956).
4. Bruce, W.R. & Van Der Gaag, H. A Quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 199, 79-80 (1963).
5. Kleinsmith, L.J. & Pierce, G.B., Jr. Multipotentiality of single embryonal carcinoma cells. Cancer Res. 24, 1544-1551 (1964).
6. Park, C.H., Bergsagel, D.E. & McCulloch, E.A. Mouse myeloma tumor stem cells: a primary cell culture assay. J. Natl. Cancer Inst. 46, 411-422 (1971).
7. Bishop, J.M. Viral oncogenes. Cell 42, 23-38 (1985).
8. Weinberg, R.A. The molecular basis of oncogenes and tumor suppressor genes. Ann. NY Acad. Sci. 758, 331-338 (1995).
9. Vogelstein, B. & Kinzler, K.W. Cancer genes and the pathways they control. Nat. Med. 10, 789-799 (2004).
10. Masters, J.R. Human cancer cell lines: fact and fantasy. Nat. Rev. Mol. Cell Biol. 1, 233-236 (2000).
11. Fuchs, E. & Raghavan, S. Getting under the skin of epidermal morphogenesis. Nat. Rev. Genet. 3, 199-209 (2002).
12. Smalley, M. & Ashworth, A. Stem cells and breast cancer: a field in transit. Nat. Rev. Cancer 3, 832-844 (2003).
13. Fuchs, E., Tumbar, T. & Guasch, G. Socializing with the neighbors: stem cells and their niche. Cell 116, 769-778 (2004).
14. Woodward, W.A., Chen, M.S., Behbod, F. & Rosen, J.M. On mammary stem cells. J. Cell Sci. 118, 3585-3594 (2005).
15. Miller, S.J., Lavker, R.M. & Sun, T.T. Interpreting epithelial cancer biology in the context of stem cells: Tumor properties and therapeutic implications. Biochim. Biophys. Acta 1756, 25-52 (2005).
16. Crowe, D.L., Parsa, B. & Sinha, U.K. Relationships between stem cells and cancer stem cells. Histol. Histopathol. 19, 505-509 (2004).
17. Young, H.E. et al. Adult reserve stem cells and their potential for tissue engineering. Cell Biochem. Biophys. 40, 1-80 (2004).
18. Beachy, P.A., Karhadkar, S.S. & Berman, D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432, 324-331 (2004).
19. Valk-Lingbeek, M.E., Bruggeman, S.W. & van Lohuizen, M. Stem cells and cancer: the polycomb connection. Cell 118, 409-418 (2004).
20. Tsai, R.Y. A molecular view of stem cell and cancer cell self-renewal. Int. J. Biochem. Cell Biol. 36, 684-694 (2004).
21. Goodell, M.A. Multipotential stem cells and 'side population' cells. Cytotherapy 4, 507-508 (2002).
22. Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648 (1994).
23. Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270 (2003).
24. Dontu, G., Al-Hajj, M., Abdallah, W.M., Clarke, M.F. & Wicha, M.S. Stem cells in normal breast development and breast cancer. Cell Prolif. 36 Suppl 1, 59-72 (2003).
25. Kim, C.F. et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121, 823-835 (2005).
26. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J. & Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988 (2003).
27. Setoguchi, T., Taga, T. & Kondo, T. Cancer stem cells persist in many cancer cell lines. Cell Cycle 3, 414-415 (2004).
28. Kondo, T., Setoguchi, T. & Taga, T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA 101, 781-786 (2004).
29. Singh, S.K. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828 (2003).
30. Hirschmann-Jax, C. et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 101, 14228-14233 (2004).
31. Locke, M., Heywood, M., Fawell, S. & Mackenzie, I.C. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res. 65, 8944-8950 (2005).
32. Patrawala, L. et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res. 65, 6207-6219 (2005).
33. Passegue, E., Jamieson, C.H., Ailles, L.E. & Weissman, I.L. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc. Natl. Acad. Sci. USA 100 Suppl 1, 11842-11849 (2003).
34. Spradling, A., Drummond-Barbosa, D. & Kai, T. Stem cells find their niche. Nature 414, 98-104 (2001).
35. Tumbar, T. et al. Defining the epithelial stem cell niche in skin. Science 303, 359-363 (2004).
36. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F. & Kirchner, T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744-749 (2005).
37. Pardal, R., Clarke, M.F. & Morrison, S.J. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3, 895-902 (2003).
38. Vitale-Cross, L., Amornphimoltham, P., Fisher, G., Molinolo, A.A. & Gutkind, J.S. Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res. 64, 8804-8807 (2004).
39. Caussinus, E. & Gonzalez, C. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat Genet (2005).
40. Lininger, R.A., Fujii, H., Man, Y.G., Gabrielson, E. & Tavassoli, F.A. Comparison of loss heterozygosity in primary and recurrent ductal carcinoma in situ of the breast. Mod. Pathol. 11, 1151-1159 (1998).
41. Prindull, G. Hypothesis: cell plasticity, linking embryonal stem cells to adult stem cell reservoirs and metastatic cancer cells? Exp. Hematol. 33, 738-746 (2005).
42. Bates, R.C. & Mercurio, A.M. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol. Ther. 4, 365-370 (2005).
43. Kai, T. & Spradling, A. Differentiating germ cells can revert into functional stem cells in Drosophila melanogaster ovaries. Nature 428, 564-569 (2004).
44. Cozzio, A. et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17, 3029-3035 (2003).
45. Harley, C.B. et al. Telomerase, cell immortality, and cancer. Cold Spring Harb. Symp. Quant. Biol. 59, 307-315 (1994).
46. Hahn, W.C. Role of telomeres and telomerase in the pathogenesis of human cancer. J. Clin. Oncol. 21, 2034-2043 (2003).
47. Morrison, S.J., Prowse, K.R., Ho, P. & Weissman, I.L. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5, 207-216 (1996).
48. Molofsky, A.V. et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425, 962-967 (2003).
49. Sherr, C.J. The ink4a/arf network in tumour suppression. Nat. Rev. Mol. Cell Biol. 2, 731-737 (2001).
50. Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843-850 (2005).
51. Allsopp, R.C., Cheshier, S. & Weissman, I.L. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J. Exp. Med. 193, 917-924 (2001).
52. Flores, I., Cayuela, M.L. & Blasco, M.A. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309, 1253-1256 (2005).
53. Sarin, K.Y. et al. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436, 1048-1052 (2005).
54. Masutomi, K. et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc. Natl. Acad. Sci. USA 102, 8222-8227 (2005).
55. Kinzler, K.W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996).
56. Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525-532 (1988).
57. Al-Hajj, M., Becker, M.W., Wicha, M., Weissman, I. & Clarke, M.F. Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 14, 43-47 (2004).
58. Brenton, J.D., Carey, L.A., Ahmed, A.A. & Caldas, C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J. Clin. Oncol. 23, 7350-7360 (2005).
59. Dean, M., Fojo, T. & Bates, S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5, 275-284 (2005).
60. Abraham, B.K. et al. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin. Cancer Res. 11, 1154-1159 (2005).
61. Glinsky, G.V., Berezovska, O. & Glinskii, A.B. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest. 115, 1503-1521 (2005).
62. Bosl, G.J. & Motzer, R.J. Testicular germ-cell cancer. N. Engl. J. Med. 337, 242-253 (1997).
63. Bhatia, R. et al. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 101, 4701-4707 (2003).